This content is machine translated Advanced NET of the midgut Radiopeptide therapy successful in disease progression Patients with advanced, progressive somatostatin receptor-positive neuroendocrine tumors (NET) of the midgut may benefit from so-called peptide-mediated radioreceptor therapy (PRRT), according to a publication in the New England Journal of…
